Psychedelics Research Links May 2021
This is all the other psychedelic research that came out in May 2021.
This is all the other psychedelic research that came out in May 2021.
The papers you must have read on the use of ketamine for mental health, from depression to suicidal ideation. This selection of research on ketamine for mental health will explore its promise in treating not only depression but also the positive effects on suicidal ideation, addiction, and further symptoms of mental health disorders.
In the Research Briefing of April 21st: 1) Psilocybin pitted against antidepressant and wins on many accounts 2) What if the anti-depressant and hallucinogenic effects of psychedelics are independent?
An experiment, done with neuronal cells from ferrets, says it shows that neurons store numbers. The study showed this by investigating these neurons separately and seeing how they respond to stimuli. In contrast to what is normally thought, that neurons only change their sensitivity to other neurons, this study showed that they are able to store temporal (time) information in the cells themselves.
In the Research Briefing of April 14th: 2) Creativity is impaired whilst under the influence of psilocybin 2) Ethical and legal considerations for clinicians with patients who use psychedelics 3) Psychedelics make it to the ‘New England Journal of Medicine’
This is all the other psychedelic research that came out in April 2021.
In the Research Briefing of April 7th: 1) Ketamine has positive benefits up to 6 weeks later 2) How ayahuasca ceremonies can lead to negative experiences
In the Research Briefing of March 31st: 1) Positive interpersonal experience during a retreat 2) What predicts your response to MDMA 3) LSD and your autonomic nervous system
In the Research Briefing of March 23rd: 1) Shamanic practitioners show similar brain changes as those on a high dose of psychedelics 2) Psychedelics and mindfulness meditation find each other 3) Naturalistic mescaline use leads to positive mental health changes
In the Research Briefing of March 17th: 1) Breaking blinds in randomized controlled trials is leading to overestimation of the outcomes 2) The positive outcomes of an ayahuasca retreat, for those who took a placebo 3) The mixed relationship between suicidality and psychedelics use